Stocks
Anixa Biosciences IncAESX
HealthcareBiotechnology
A clinical-stage biopharmaceutical company developing immunotherapies and cancer vaccines, including a vaccine for triple-negative breast cancer and a chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer. Its lead programs are in early clinical trials, and investors track the stock for its potential in oncology and its partnerships with research institutions.
Congressional Interest in Anixa Biosciences Inc (AESX)
1 member of Congress has disclosed 1 trade in Anixa Biosciences Inc (AESX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading AESX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-02-15 | KENNY MARCHANT | sell | $1K-$15K |